One of the most consequential changes in 2026 is the loss of exclusivity for semaglutide, beginning in early 2026 across major markets including India, China, Brazil, Turkey and Canada, with semaglutide having lost exclusivity in India on 20th March 2026
Is GLP-1 a hormone: whether and when
The goal of the initial evaluation is to find out if the blood is originating from the lower GI tract, check for the severity of the bleeding, find the most appropriate setting for the patient, and implement the necessary supportive measures before initiating resuscitation
Formularies arrange covered drugs into tiers, with generics in the lower tiers and brand-name or specialty medications in the higher ones
Bioavailability: Why Most Supplements Fall Short When choosing a glutathione supplement, the biggest hurdle is not the doseit is the delivery